Al Kraus - May 6, 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role: Director
Signature: /s/ Kathleen P. Bloch attorney-in-fact for Al Kraus
Stock symbol: CTSO
Transactions as of: May 6, 2022
Transactions value $: $9,795
Form type: 4
Date filed: 5/9/2022, 04:13 PM
Previous filing: Sep 2, 2021
Next filing: Aug 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTSO	Common Stock	Purchase	$9.8K	+5K	+4%	$1.96	130K	May 6, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 60,746 shares of common stock owned by the reporting person, inclusive of the 5,000 shares of common stock purchased in the open market and reported on this Form 4.

Content

Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 60,746 shares of common stock owned by the reporting person, inclusive of the 5,000 shares of common stock purchased in the open market and reported on this Form 4.